Search
Search Results
-
Neuropsychiatric post-acute sequelae of COVID-19: prevalence, severity, and impact of vaccination
The potential long-term neuropsychiatric effects of COVID-19 are of global concern. This study aimed to determine the prevalence and predictors of...
-
Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
BackgroundFew studies have directly compared the risk and magnitude of post-acute sequelae following COVID-19 and influenza, and most of these...
-
Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae
PurposeOlfactory dysfunction (OD) commonly accompanies coronavirus disease 2019 (COVID-19). We investigated the kinetics of OD resolution following...
-
Serological response to vaccination in post-acute sequelae of COVID
BackgroundIndividuals with post-acute sequelae of COVID (PASC) may have a persistence in immune activation that differentiates them from individuals...
-
Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19
PurposePost-acute sequelae of COVID-19 (PASC) affect approximately 10% of convalescent patients. The spectrum of symptoms is broad and heterogeneous...
-
Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19
BackgroundPersistent neuropsychiatric symptoms following acute COVID-19 infection are frequently reported. These include anxiety, depression,...
-
Development of a decentralized cohort for studying post-acute sequelae of COVID-19 in India in the Data4life Study
BackgroundDecentralized, digital health studies can provide real-world evidence of the lasting effects of COVID-19 on physical, socioeconomic,...
-
International electronic health record-derived post-acute sequelae profiles of COVID-19 patients
The risk profiles of post-acute sequelae of COVID-19 (PASC) have not been well characterized in multi-national settings with appropriate controls. We...
-
The ambulatory care of patients with post-acute sequelae of COVID-19
BackgroundThere is an increasing number of patients that do not make a rapid or full recovery from a SARS-CoV-2 infection, the Coronavirus Disease...
-
Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic
IntroductionTo compare the time distribution of initial COVID-19 among patients with self-reported post-acute sequelae of COVID-19 (PASC).
...
-
Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities
Purpose of ReviewPost Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2), also known as PASC, and frequently referred to...
-
Post-acute Cardiovascular Sequelae of COVID-19: an Overview of Functional and Imaging Insights
Purpose of ReviewTo evaluate the potential role of advanced cardiac imaging and cardiopulmonary exercise testing in the diagnosis and evaluation of...
-
Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 220 countries and territories...
-
Post-COVID-19 Sequelae in Children
Coronavirus disease 19 (COVID-19), caused by the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), has been implicated in having...
-
Bronchoscopy in the post-acute phase of COVID-19: an observational study
BackgroundBronchoscopy is a useful technique adopted in the management of patients with COVID-19. 10–40% of COVID-19 survivors experience persistent...
-
Effects of pulmonary rehabilitation on functional and psychological parameters in post-acute sequelae of SARS-CoV-2 infection (PASC) patients
BackgroundCOVID-19 survivors may develop long-term symptoms of fatigue, dyspnea, mental health issues, and functional limitations: a condition termed...
-
Identifying Post-Acute Sequelae of SARS-CoV-2 Among Children in New York State Medicaid Managed Care
Persons who contract COVID-19 are at risk of develo** post-acute sequelae of SARS-CoV-2 (PASC). The objective of this study was to describe the...
-
Post-acute Sequelae in COVID-19 Survivors: an Overview
In the acute phase of SARS-CoV-2 infection, varying degrees of clinical manifestations have been noticed in patients. Some patients who recovered...
-
Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Develo** Post-Acute Depression and Anxiety
Background and ObjectivesClinical manifestations of coronavirus disease 2019 (COVID-19) often persist after acute disease resolution. Underlying...
